References
- Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., Ronald, A., Tumwesigye, E., Were, E., Fife, K. H., Kiarie, J., Farquhar, C., John-Stewart, G., Kakia, A., Odoyo, J., Mucunguzi, A., … Celum, C. (2012). Partners PrEP study team: Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367(5), 399–410. https://doi.org/10.1056/NEJMoa1108524
- Calabrese, S. K., Magnus, M., Mayer, K. H., Krakower, D. S., Eldahan, A. I., Gaston Hawkins, L. A., Hansen, N. B., Kershaw, T. S., Underhill, K., Betancourt, J. R., Dovidio, J. F., & Selvey, L. A. (2016). Putting PrEP into practice: Lessons learned from early-adopting U.S. providers’ firsthand experiences providing HIV pre-exposure prophylaxis and associated care. PLoS ONE, 11(6), e0157324. https://doi.org/10.1371/journal.pone.0157324. https://www.scopus.com/inward/record.uri?eid=2-s2.0-84975882061&doi=10.1371%2fjournal.pone.0157324&partnerID=40&md5=69786a6696948c0dbafcbe651d7af0a5; https://journals.plos.org/plosone/article/file?id=10.1371/jo urnal.pone.0157324&type=printable
- Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A, Leethochawalit, M., Chiamwongpaet, S., Kitisin, P., Natrujirote, P., Kittimunkong, S., Chuachoowong, R., Gvetadze, R. J, McNicholl, J. M, Paxton, L. A, Curlin, M. E, Hendrix, C. W, & Vanichseni, S. (2013). Bangkok Tenofovir study group: Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir study): A randomised, double-blind, placebo-controlled phase 3 trial. The Lancet, 381(9883), 2083–2090. https://doi.org/10.1016/S0140-6736(13)61127-7
- Davies, O., Ustianowski, A., & Fox, J. (2016). Pre-exposure prophylaxis for HIV prevention: Why, what, who and how. Infectious Diseases and Therapy, 5(4), 407–416. https://doi.org/10.1007/s40121-016-0128-8
- Desai, M., Gafos, M., Dolling, D., McCormack, S., Nardone, A., & Study, P. (2016). Healthcare providers’ knowledge of, attitudes to and practice of pre-exposure prophylaxis for HIV infection. Hiv Medicine, 17(2), 133–142. https://doi.org/10.1111/hiv.12285. <Go to ISI>://WOS:000369002600006
- Eaton, L., Driffin, D., Smith, H., Conway-Washington, C., White, D., & Cherry, C. (2014). Psychosocial factors related to willingness to use pre-exposure prophylaxis for HIV prevention among Black men who have sex with men attending a community event. Sexual Health, 11(3), 244–251. https://doi.org10.1071/SH14022. https://search.ebscohost.com/login.aspx?direct=true&db=rzh&AN=109673674&site=ehost-live; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331017/pdf/nihms658692.pdf
- Erzberger, C., & Prein, G. (1997). Triangulation: Validity and empirically-based hypothesis construction. Quality and Quantity, 31(2), 141–154. https://doi.org/10.1023/A:1004249313062
- Farmer, T., Robinson, K., Elliott, S. J., & Eyles, J. (2006). Developing and implementing a triangulation protocol for qualitative health research. Qualitative Health Research, 16(3), 377–394. https://doi.org/10.1177/1049732305285708
- Ford, N., Irvine, C., Shubber, Z., Baggaley, R., Beanland, R., & Vitoria, M., Doherty, M., Mills, E. J., Calmy, A. (2014). Adherence to HIV postexposure prophylaxis: A systematic review and meta-analysis. Aids (london, England), 28(18), 2721–2727. https://doi.org/10.1097/QAD.0000000000000505
- Foster, R. L. (1997). Addressing epistemologic and practical issues in multimethod research: A procedure for conceptual triangulation. Advances in Nursing Science, 20(2), 1–12. https://doi.org/10.1097/00012272-199712000-00002. https://journals.lww.com/advancesinnursingscience/Fulltext/1997/12000/Addressing_Epistemologic_and_Practical_Issues_in.2.aspx
- Freeborn, K., & Portillo, C. J. (2018). Does preexposure prophylaxis for HIV prevention in men who have sex with men change risk behaviour? A systematic review. Journal of Clinical Nursing, 27(17–18), 3254–3265. https://doi.org/10.1111/jocn.13990
- Gafos, M., Horne, R., Nutland, W., Bell, G., Rae, C., Wayal, S., Rayment, M., Clarke, A., Schembri, G., Gilson, R., McOwan, A., Sullivan, A., Fox, J., Apea, V., Dewsnap, C., Dolling, D., White, E., Brodnicki, E., Wood, G., Dunn, D., … McCormack, S. (2019). The context of sexual risk behaviour among men who have sex with men seeking PrEP, and the impact of PrEP on sexual behaviour. AIDS And Behavior, 23(7), 1708–1720. https://doi.org/10.1007/s10461-018-2300-5
- Grov, C., Whitfield, T., Rendina, H., Ventuneac, A., & Parsons, J. T. (2015). Willingness to take PrEP and potential for risk compensation among highly sexually active gay and bisexual men … pre-exposure prophylaxis. AIDS and Behavior, 19(12), 2234–2244. https://doi.org/10.1007/s10461-015-1030-1. https://search.ebscohost.com/login.aspx?direct=true&db=rzh&AN=110400692&site=ehost-live; https://link.springer.com/content/pdf/10.1007%2Fs10461-015-1030-1.pdf
- Hillis, A., Germain, J., Hope, V., McVeigh, J., & Van Hout, M. C. (2020). Pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men (MSM): A scoping review on PrEP service delivery and programming. AIDS And Behavior, 24(11), 3056–3070. https://doi.org/10.1007/s10461-020-02855-9
- Holloway, I., Tan, D., Gildner, J., Beougher, S., Pulsipher, C., Montoya, J., Plant, A., & Leibowitz, A. (2017). Facilitators and barriers to pre-exposure prophylaxis willingness among young men who have sex with men who use geosocial networking applications in California. AIDS Patient Care and STDs, 31(12), 517–527. https://doi.org/10.1089/apc.2017.0082. https://search.ebscohost.com/login.aspx?direct=true&db=rzh&AN=126585297&site=ehost-live
- Klevens, R., Martin, B., Doherty, R., Fukuda, H., Cranston, K., & DeMaria, A. (2018). Factors associated with pre-exposure prophylaxis in a highly insured population of urban men who have sex with men, 2014. AIDS and Behavior, 22(4), 1201–1208. https://doi.org/10.1007/s10461-017-1879-2. https://search.ebscohost.com/login.aspx?direct=true&db=rzh&AN=128815493&site=ehost-live; https://link.springer.com/content/pdf/10.1007%2Fs10461-017-1879-2.pdf
- Lelutiu-Weinberger, C., & Golub, S. A. (2016). Enhancing PrEP access for Black and Latino men who have sex with men. JAIDS Journal of Acquired Immune Deficiency Syndromes, 73(5), 547–555. https://doi.org/10.1097/QAI.0000000000001140. https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&AN=27454250&site=ehost-live; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110381/pdf/nihms-803533.pdf
- McCormack, S., Dunn, D. T., Desai, M., Dolling, D. I., Gafos, M., Gilson, R., Sullivan, A. K, Clarke, A., Reeves, I., Schembri, G., Mackie, N., Bowman, C., Lacey, C. J, Apea, V., Brady, M., Fox, J., Taylor, S., Antonucci, S., Khoo, S. H, Rooney, J., … Gill, O. N. (2016). Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): Effectiveness results from the pilot phase of a pragmatic open-label randomised trial. The Lancet, 387(10013), 53–60. https://doi.org/10.1016/S0140-6736(15)00056-2
- Molina, J. M., Capitant, C., Spire, B., Pialoux, G., Cotte, L., Charreau, I., Tremblay, C., Le Gall, J.-M., Cua, E., Pasquet, A., Raffi, F., Pintado, C., Chidiac, C., Chas, J., Charbonneau, P., Delaugerre, C., Suzan-Monti, M., Loze, B., Fonsart, J., Peytavin, G., … Delfraissy, J. F. (2015). On-demand preexposure prophylaxis in menat high risk for HIV-1 infection. New England Journal of Medicine, 373(23), 2237–2246. https://doi.org/10.1056/NEJMoa1506273
- NHS England. (2017). PrEP IMPACT trial questions and answers. https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-impact-trial-questions-and-answers/#when-will-the-trial-start
- Nugroho, A., Erasmus, V., Zomer, T. P., Wu, Q., & Richardus, J. H. (2017). Behavioral interventions to reduce HIV risk behavior for MSM and transwomen in Southeast Asia: A systematic review. AIDS Care, 29(1), 98–104. https://doi.org/10.1080/09540121.2016.1200713
- O’Halloran, C., Sun, S., Nash, S. G., Brown, A., Connor, N., Delpech, V., Gill, N., Croxford, S., & Sullivan, A. (2019). HIV in the United Kingdom: Towards zero 2030. 2019 report.
- Patel, R. R., Chan, P. A., Harrison, L. C., Mayer, K. H., Nunn, A., Mena, L. A., & Powderly, W. G. (2018). Missed opportunities to prescribe HIV pre-exposure prophylaxis by primary care providers in Saint Louis, Missouri. LGBT Health, 5(4), 250–256. https://doi.org/10.1089/lgbt.2017.0101. https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&AN=29688800&site=ehost-live; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994151/pdf/lgbt.2017.0101.pdf
- Pietkiewicz, I., & Smith, J. A. (2012). A practical guide to using interpretative phenomenological analysis in qualitative research psychology. Psychological Journal, 18(2), 361–369. https://doi.org/10.14691/CPPJ.20.1.7.
- PrEP IMPACT Trial. (2020). PrEP IMPACT Trial. https://www.prepimpacttrial.org.uk/about-prep
- PrEP Watch. (2020). Global PrEP Tracker. https://www.prepwatch.org/resource/global-prep-tracker/
- Rivet Amico, K., & Bekker, L. G. (2019). Global PrEP roll-out: Recommendations for programmatic success. The Lancet HIV, 6(2), e137–e140. https://doi.org/10.1016/S2352-3018(19)30002-5
- Smith, J. A. (2009). Interpretative phenomenological analysis. Sage.
- Smith, J. A., Flowers, P., & Larkin, M. (2009). Interpretative phenomenological analysis. Sage.
- Stover, J., Bollinger, L., Izazola, J. A., Loures, L., DeLay, P., Ghys, P. D., & Lima, V. D. (2016). What is required to end the AIDS epidemic as a public health threat by 2030? The cost and impact of the fast-track approach. PLoS ONE, 11(5), e0154893. https://doi.org/10.1371/journal.pone.0154893
- Sullivan, P. S., & Siegler, A. J. (2018). Getting pre-exposure prophylaxis (PrEP) to the people: Opportunities, challenges and emerging models of PrEP implementation. Sexual Health, 15(6), 522–527. https://doi.org/10.1071/SH18103
- Sun, C. J., Anderson, K. M., Bangsberg, D., Toevs, K., Morrison, D., Wells, C., Clark, P., & Nicolaidis, C. (2019). Access to HIV pre-exposure prophylaxis in practice settings: A qualitative study of sexual and gender minority adults’ perspectives. Journal of General Internal Medicine, https://doi.org/10.1007/s11606-019-04850-w; https://link.springer.com/content/pdf/10.1007%2Fs11606-019-04850-w.pdf
- Tong, A., Sainsbury, P., & Craig, J. (2007). Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care, 19(6), 349–357. https://doi.org/10.1093/intqhc/mzm042
- Traeger, M. W., Schroeder, S., Wright, E., Hellard, M., Cornelisse, V., Doyle, J., & Stoové, M. (2018). Effects of pre-exposure prophylaxis for the prevention of human immunodeficiency virus infection on sexual risk behavior in men who have sex with men: A systematic review and meta-analysis. Clinical Infectious Diseases, 67(5), 676–686. https://doi.org/10.1093/cid/ciy182
- UNAIDS. (2014). The gap report 2014. https://files.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2014/UNAIDS_Gap_report_en.pdf
- UNAIDS. (2016). Maximizing the potential of a new HIV prevention method: PrEP. https://www.unaids.org/en/resources/presscentre/featurestories/2016/november/20161101_PrEP
- Vanhamel, J., Rotsaert, A., Reyniers, T., Nöstlinger, C., Marie Laga, M., Landeghem, E. V., & Vuylsteke, B. (2020). The current landscape of pre-exposure prophylaxis service delivery models for HIV prevention: A scoping review. BMC Health Services Research, 20(704), 1–18. https://doi.org/10.1186/s12913-020-05568-w.
- Witzel, T. C., Nutland, W., & Bourne, A. (2018). What qualities in a potential HIV pre-exposure prophylaxis service are valued by black men who have sex with men in London? A qualitative acceptability study. International Journal of STD & AIDS, 29(8), 760–765. https://doi.org/10.1177/0956462418755224. https://search.ebscohost.com/login.aspx?direct=true&db=rzh&AN=130232147&site=ehost-live
- World Health Organization. (2015). Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. https://apps.who.int/medicinedocs/documents/s22247en/s22247en.pdf
- World Health Organization. (2016). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach, second edition. https://www.who.int/hiv/pub/arv/arv-2016/en/